Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives
| العنوان: | Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives |
|---|---|
| المؤلفون: | Leo J. Hofland, Anne Barlier, Diego Ferone, Georges Weryha, Thomas Cuny, Federico Gatto, Richard A Feelders |
| المساهمون: | Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service d'Endocrinologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Internal Medicine, Dumonceaud, Corinne |
| المصدر: | Annales d'Endocrinologie Annales d'Endocrinologie, 2015, 76 (1), pp.43-58 Annales d'Endocrinologie, Elsevier Masson, 2015, 76 (1), pp.43-58 Annales d' Endocrinologie, 76(1), 43-58. Elsevier Masson |
| بيانات النشر: | HAL CCSD, 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | Oncology, Adenoma, Adult, medicine.medical_specialty, ACTH-Secreting Pituitary Adenoma, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Thyrotropin, Pituitary neoplasm, Somatostatin analog, Endocrinology, Internal medicine, Acromegaly, Medicine, Humans, Pituitary Neoplasms, Prolactinoma, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], [SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM], Pituitary adenomas, business.industry, General Medicine, Cushing's disease, medicine.disease, Surgery, Radiation therapy, Diabetes and Metabolism, Dopamin agonist, Dopamine Agonists, Growth Hormone-Secreting Pituitary Adenoma, business, Somatostatin |
| الوصف: | International audience; Pituitary adenomas (PA) represent in the majority of cases, benign tumors whose treatment currently associate surgery, medical therapies and radiotherapy in a multidisciplinary approach. While trans-sphenoidal surgery remains, except for prolactin-secreting adenomas, the first-line treatment of PA, it can considerably be hampered by the existence of an invasive and/or aggressive tumor for which medical therapies are often requested. In this review, we extensively discuss, both at molecular and clinical levels, the medical therapies currently used and in development in the different phenotypes of pituitary adenomas. |
| اللغة: | English |
| تدمد: | 0003-4266 2213-3941 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5cc6da6b91849649393566985ac0af5Test https://hal.science/hal-01176930Test |
| حقوق: | RESTRICTED |
| رقم الانضمام: | edsair.doi.dedup.....b5cc6da6b91849649393566985ac0af5 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 00034266 22133941 |
|---|